Concepedia

Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer

William Morris, Scott Tyldesley, S. Rodda, Ross Halperin, Howard Pai, Michael McKenzie, Graeme Duncan, Gerard Morton, Jeremy Hamm, Nevin Murray

International Journal of Radiation Oncology*Biology*Physics · 2016 · 732 citations · 23 references

DOI

Concepts

References

23

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

David P. Dearnaley, Isabel Syndikus, Helen Mossop et al. · The Lancet Oncology · 2016 · 1.3K citations · Full text

, , +17

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study

M. Bolla, Geertjan van Tienhoven, Padraig Warde et al. · The Lancet Oncology · 2010 · 944 citations

, , +17

Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer

Peter Hoskin, Ana M. Rojas, Peter Bownes et al. · Radiotherapy and Oncology · 2012 · 494 citations

, , +17

Randomized Trial of Hypofractionated External-Beam Radiotherapy for Prostate Cancer

Alan Pollack, Gail Walker, Eric M. Horwitz et al. · Journal of Clinical Oncology · 2013 · 466 citations · Full text

, , +17

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial

David P. Dearnaley, Gordana Jovic, Isabel Syndikus et al. · The Lancet Oncology · 2014 · 462 citations · Full text

, , +14